IL12 in acute viral infectious disease

被引：29
|
作者：
Biron, CA
Orange, JS
机构：
[1] Division of Biology and Medicine, Brown University, Providence, RI
来源：
RESEARCH IN IMMUNOLOGY | 1995年 / 146卷 / 7-8期
关键词：
D O I：
10.1016/0923-2494(96)83036-7
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：590 / 597
页数：8
相关论文
共 50 条
  • [21] IL12 and the human immune response to mycobacteria - Reply
    Modlin
    Barnes
    RESEARCH IN IMMUNOLOGY, 1995, 146 (7-8): : 531 - 531
  • [22] IL12, a direct stimulator and indirect inhibitor of haematopoiesis
    Jacobsen, SEW
    RESEARCH IN IMMUNOLOGY, 1995, 146 (7-8): : 506 - 513
  • [23] Granulomatous lymphadenitis revealing a deficiency in receptor IL12
    Kamoun, Fatma
    Sfaihi, Lamia
    Ben Mustapha, Imen
    Ben Ameur, Salma
    Barbouche, Mohamed Ridha
    Hachicha, Mongia
    PRESSE MEDICALE, 2017, 46 (03): : 346 - 348
  • [24] IL12/IL23 Inhibition in the Treatment of Psoriatic Arthritis
    Mahta Mortezavi
    Christopher Ritchlin
    Current Treatment Options in Rheumatology, 2015, 1 (2) : 197 - 209
  • [25] IL12 PREVENTS AUTOIMMUNITY IN A MURINE MODEL OF SLE
    VIA, CS
    RUS, V
    GATELY, M
    FINKELMAN, FD
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S63 - S63
  • [26] FXTAS presents with upregulation of the cytokines IL12 and TNFα
    Dufour, Brett D.
    Amina, Sarwat
    Martinez-Cerdeno, Veronica
    PARKINSONISM & RELATED DISORDERS, 2021, 82 : 117 - 120
  • [27] UNDERSTANDING THE ROLE OF THE IL12/IL35 BALANCE IN SJOGREN SYNDROME
    Fogel, O.
    Riviere, E.
    Seror, R.
    Nocturne, G.
    Ly, B.
    Boudaoud, S.
    Gottenberg, J. -E.
    Dubost, J. -J.
    Le Guern, V.
    Dieude, P.
    Chanson, P.
    Nititham, J.
    Taylor, K.
    Criswell, L.
    Mariette, X.
    Miceli-Richard, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 948 - 948
  • [28] Influence of IL12 on the maturation of human naive T cells
    Delespesse, G
    Wu, CY
    Shu, U
    Byun, DG
    RESEARCH IN IMMUNOLOGY, 1995, 146 (7-8): : 461 - 464
  • [29] IL12/23 or selective IL23 inhibition for the management of moderate-to-severe Crohn's disease?
    Ma, Christopher
    Panaccione, Remo
    Khanna, Reena
    Feagan, Brian G.
    Jairath, Vipul
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2019, 38-39
  • [30] Exosome Surface Display of IL12 Results in Tumor-Retained Pharmacology with Superior Potency and Limited Systemic Exposure Compared with Recombinant IL12
    Lewis, Nuruddeen D.
    Sia, Chang Ling
    Kirwin, Katherine
    Haupt, Sonya
    Mahimkar, Gauri
    Zi, Tong
    Xu, Ke
    Dooley, Kevin
    Jang, Su Chul
    Choi, Bryan
    Boutin, Adam
    Grube, Andrew
    McCoy, Christine
    Sanchez-Salazar, Jorge
    Doherty, Michael
    Gaidukov, Leonid
    Estes, Scott
    Economides, Kyriakos D.
    Williams, Douglas E.
    Sathyanarayanan, Sriram
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (03) : 523 - 534
12345